Table 1

Baseline characteristics of the patients

VariableIAT
(n=62)
IVT
(n=31)
p Value
Demographic characteristics
Age, years66.6±11.264.7±11.50.464
Male, n (%)35 (56.5)16 (51.6)0.658
Clinical characteristics
NIHSS score23.2±4.721.4±4.20.066
mRS score55
Duration to treatment, hours5.0 (4.0,6.3)4.0 (3.0,4.5)<0.001
Median (IQR)
SBP (mm Hg)150.6±14.5152.5±12.40.532
DBP (mm Hg)85.9±9.788.6±10.80.224
Blood glucose (mmol/L)7.9±3.18.4±3.60.571
TC (mmol/L)5.0±1.65.1±1.50.853
TG (mmol/L)1.4±0.81.3±0.70.354
HDL (mmol/L)1.2±0.51.4±0.40.221
LDL (mmol/L)3.0±1.12.9±1.10.629
Medical history
Hypertension62 (100)31 (100)
Diabetes21 (33.9)8 (25.8)0.429
Hyperlipidemia21 (33.9)11 (35.5)0.877
Smoking10 (16.1)6 (19.4)0.698
Alcohol abuse12 (19.4)4 (12.9)0.437
0.120
Previous cerebral infarction8 (12.9)8 (25.8)
Site of occlusion, n (%)
MCA21 (33.9)14 (45.2)0.457
ICA13 (21.0)7 (22.6)
BA28 (45.2)10 (32.3)
  • Data are the mean±SD unless otherwise indicated.

  • An mRS score of 5 was a requirement to be eligible for inclusion in the study

  • BA, basilar artery; DBP, diastolic blood pressure; IAT, multimodal intra-arterial treatment; ICA, internal carotid artery; IVT, intravenous thrombolysis; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; TC, total cholesterol, TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein.